Stock anomaly | Moderna (MRNA.US) rises more than 9% on rumors of acquisition negotiations with at least one major pharmaceutical company.

According to the Securities Times app, on Thursday, the stock price of Moderna (MRNA.US) rose. As of the time of writing, the stock price has increased by over 9% to $26.95. On the news front, a person familiar with the discussions revealed that the company is in talks with at least one large pharmaceutical company for a major acquisition deal.